Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn's Disease
59 Crohn's disease patients with IFX treatment failure were randomized to an intensified IFX regimen or personalized treatment. Health-related quality of life and productivity were assessed at treatment failure and after 4, 8, 12 and 20 weeks.
